Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 4/2009

01-04-2009 | Original Paper

Enhanced expression of trophinin promotes invasive and metastatic potential of human gallbladder cancer cells

Authors: Xin-Zhong Chang, Jie Yu, Xue-Hui Zhang, Jian Yin, Tao Wang, Xu-Chen Cao

Published in: Journal of Cancer Research and Clinical Oncology | Issue 4/2009

Login to get access

Abstract

Purpose

To study effects of trophinin on the metastatic potential of human gallbladder cancer cells and its potential mechanism.

Materials and methods

Expression of trophinin in the highly metastatic GBC-SDHi cells was investigated by real time RT-PCR and western blot. Recombinant expression plasmid vector of the human trophinin gene was constructed and transfected into GBC-SD cells. Effects of trophinin on the invasion of GBC-SD cells were investigated by adhesion assay and invasion assay in vitro. The siRNA was used to down-regulate the expression of trophinin. Some genes related to the invasion and metastasis of cancer were determined by real time RT-PCR and western blot. The pulmonary metastasis regulated by trophinin was determined in the nude mice.

Results

Overexpression of trophinin in GBC-SDHi cells was confirmed compared with its parental counterparts. Up-regulation of trophinin enhanced the in vitro invasion in the GBC-SD/TRO cells. The enhancement was associated with increasing integrin α3, MMP-7, MMP-9, and Ets-1 expression. The results were further demonstrated by RNA interference experiment in vitro. In in vivo study, we also demonstrated that trophinin-transfected gallbladder cancer cells had more pulmonary metastases than the vector-transfected one or its parental counterparts.

Conclusion

Overexpression of trophinin leads to a more invasive phenotype and metastatic potential in human gallbladder cancer, at least in part, through regulating integrin α3, MMP-7, MMP-9, and Ets-1 expression.
Literature
go back to reference Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH et al (2007a) Identification of the functional role of AF1Q in the progression of breast cancer. Breast Cancer Res Treat 111(1):65–78PubMedCrossRef Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH et al (2007a) Identification of the functional role of AF1Q in the progression of breast cancer. Breast Cancer Res Treat 111(1):65–78PubMedCrossRef
go back to reference Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH et al (2007b) Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 9:R76. doi:10.1186/bcr1789 PubMedCrossRef Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH et al (2007b) Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 9:R76. doi:10.​1186/​bcr1789 PubMedCrossRef
go back to reference Chang XZ, Wang ZM, Yu JM, Tian FG, Jin W, Zhang Y et al (2007c) Isolation of a human gallbladder cancer cell clone with high invasive phenotype in vitro and metastatic potential in orthotopic model and inhibition of its invasiveness by heparanase antisense oligodeoxynucleotides. Clin Exp Metastasis 24:25–38. doi:10.1007/s10585-006-9053-7 PubMedCrossRef Chang XZ, Wang ZM, Yu JM, Tian FG, Jin W, Zhang Y et al (2007c) Isolation of a human gallbladder cancer cell clone with high invasive phenotype in vitro and metastatic potential in orthotopic model and inhibition of its invasiveness by heparanase antisense oligodeoxynucleotides. Clin Exp Metastasis 24:25–38. doi:10.​1007/​s10585-006-9053-7 PubMedCrossRef
go back to reference Chen X, Su Y, Fingleton B, Acuff H, Matrisian LM, Zent R et al (2005) Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells. Int J Cancer 116:52–61. doi:10.1002/ijc.20997 PubMedCrossRef Chen X, Su Y, Fingleton B, Acuff H, Matrisian LM, Zent R et al (2005) Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells. Int J Cancer 116:52–61. doi:10.​1002/​ijc.​20997 PubMedCrossRef
go back to reference Fouchier F, Penel C, Pierre Montero M, Bremond P, Champion S (2007) Integrin alphavbeta6 mediates HT29-D4 cell adhesion to MMP-processed fibrinogen in the presence of Mn(2+). Eur J Cell Biol 86(3):143–160PubMedCrossRef Fouchier F, Penel C, Pierre Montero M, Bremond P, Champion S (2007) Integrin alphavbeta6 mediates HT29-D4 cell adhesion to MMP-processed fibrinogen in the presence of Mn(2+). Eur J Cell Biol 86(3):143–160PubMedCrossRef
go back to reference Fukuda MN, Nozawa S (1999) Trophinin, tastin, and bystin: a complex mediating unique attachment between trophoblastic and endometrial epithelial cells at their respective apical cell membranes. Semin Reprod Endocrinol 17:229–234PubMedCrossRef Fukuda MN, Nozawa S (1999) Trophinin, tastin, and bystin: a complex mediating unique attachment between trophoblastic and endometrial epithelial cells at their respective apical cell membranes. Semin Reprod Endocrinol 17:229–234PubMedCrossRef
go back to reference Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H et al (2004) Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202:14–22. doi:10.1002/path.1479 PubMedCrossRef Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H et al (2004) Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202:14–22. doi:10.​1002/​path.​1479 PubMedCrossRef
go back to reference Morini M, Mottolese M, Ferrari N, Ghiorzo F, Buglioni S, Mortarini R et al (2000) The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer 87:336–342. doi:10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3PubMedCrossRef Morini M, Mottolese M, Ferrari N, Ghiorzo F, Buglioni S, Mortarini R et al (2000) The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer 87:336–342. doi:10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3PubMedCrossRef
go back to reference Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M (1996) Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer 74:1406–1412PubMed Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M (1996) Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer 74:1406–1412PubMed
go back to reference Ozaki I, Mizuta T, Zhao G, Yotsumoto H, Hara T, Kajihara S et al (2000) Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 60:6519–6525PubMed Ozaki I, Mizuta T, Zhao G, Yotsumoto H, Hara T, Kajihara S et al (2000) Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 60:6519–6525PubMed
go back to reference Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B (2003) Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci USA 100:9482–9487. doi:10.1073/pnas.1633689100 PubMedCrossRef Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B (2003) Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci USA 100:9482–9487. doi:10.​1073/​pnas.​1633689100 PubMedCrossRef
go back to reference Sasaki H, Yukiue H, Moiriyama S, Kobayashi Y, Nakashima Y, Kaji M et al (2001) Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J Surg Res 101:242–247. doi:10.1006/jsre.2001.6279 PubMedCrossRef Sasaki H, Yukiue H, Moiriyama S, Kobayashi Y, Nakashima Y, Kaji M et al (2001) Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J Surg Res 101:242–247. doi:10.​1006/​jsre.​2001.​6279 PubMedCrossRef
go back to reference Sun YX, Fang M, Wang J, Cooper CR, Pienta KJ, Taichman RS (2007) Expression and activation of alpha(v)beta(3) integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate 67:61–73. doi:10.1002/pros.20500 PubMedCrossRef Sun YX, Fang M, Wang J, Cooper CR, Pienta KJ, Taichman RS (2007) Expression and activation of alpha(v)beta(3) integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate 67:61–73. doi:10.​1002/​pros.​20500 PubMedCrossRef
go back to reference Suzuki N, Zara J, Sato T, Ong E, Bakhiet N, Oshima RG et al (1998) A cytoplasmic protein, bystin, interacts with trophinin, tastin, and cytokeratin and may be involved in trophinin-mediated cell adhesion between trophoblast and endometrial epithelial cells. Proc Natl Acad Sci USA 95:5027–5032. doi:10.1073/pnas.95.9.5027 PubMedCrossRef Suzuki N, Zara J, Sato T, Ong E, Bakhiet N, Oshima RG et al (1998) A cytoplasmic protein, bystin, interacts with trophinin, tastin, and cytokeratin and may be involved in trophinin-mediated cell adhesion between trophoblast and endometrial epithelial cells. Proc Natl Acad Sci USA 95:5027–5032. doi:10.​1073/​pnas.​95.​9.​5027 PubMedCrossRef
go back to reference Yamamoto H, Horiuchi S, Adachi Y, Taniguchi H, Nosho K, Min Y et al (2004) Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer. Carcinogenesis 25:325–332. doi:10.1093/carcin/bgh011 PubMedCrossRef Yamamoto H, Horiuchi S, Adachi Y, Taniguchi H, Nosho K, Min Y et al (2004) Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer. Carcinogenesis 25:325–332. doi:10.​1093/​carcin/​bgh011 PubMedCrossRef
Metadata
Title
Enhanced expression of trophinin promotes invasive and metastatic potential of human gallbladder cancer cells
Authors
Xin-Zhong Chang
Jie Yu
Xue-Hui Zhang
Jian Yin
Tao Wang
Xu-Chen Cao
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 4/2009
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-008-0492-1

Other articles of this Issue 4/2009

Journal of Cancer Research and Clinical Oncology 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.